Annovis Bio (NYSE:ANVS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Annovis Bio (ANVS) operate in?

Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Annovis Bio Stock (NYSE: ANVS) stock price, news, charts, stock research, profile.

Open	$11.10
Close	$15.46
Volume / Avg.	22.11M / 1.51M
Day Range	11.10 - 17.32
52 Wk Range	4.53 - 22.49
Market Cap	$167.57M
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	77
Short Interest	15.27%
Days to Cover	5.96

Recent News

Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family

Avi Kapoor

What's Going On With Annovis Shares Today?

Annovis Bio shares rise in premarket trading on positive Phase III Parkinson's study results for buntanetap, showing cognitive improvements and stability compared to placebo.

Nabaparna Bhattacharya

Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today

On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory.

Benzinga Neuro

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

May

Jun

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Annovis Bio Inc

Sector

Health Care

Industry

Biotechnology

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Annovis Bio (ANVS) stock?

You can purchase shares of Annovis Bio (NYSE:ANVS) through any online brokerage.

View our list of the best stock brokerages

Who are Annovis Bio (ANVS) competitors?

Other companies in Annovis Bio’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Atossa Therapeutics (NASDAQ:ATOS), Tevogen Bio Holdings (NASDAQ:TVGN) and aTyr Pharma (NASDAQ:ATYR).

What is the target price for Annovis Bio (ANVS) stock?

There is no analysis for Annovis Bio.

What is the forecast for Annovis Bio (ANVS) stock?

Annovis Bio has a consensus price target of $38.17.

Current stock price for Annovis Bio (ANVS)?

The stock price for Annovis Bio (NYSE: ANVS) is $15 last updated Today at July 8, 2024 at 5:28 PM EDT.

Does Annovis Bio (ANVS) pay a dividend?

There are no upcoming dividends for Annovis Bio.

When is Annovis Bio (NYSE:ANVS) reporting earnings?

Annovis Bio’s Q2 earnings are confirmed for Tuesday, August 13, 2024.

Is Annovis Bio (ANVS) going to split?

There is no upcoming split for Annovis Bio.

What sector and industry does Annovis Bio (ANVS) operate in?

Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Annovis Bio

Annovis Bio (ANVS) Forecast